Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fariba Dehghanian

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Gene|October 7, 2014
Comparative insight into expression of recombinant human VEGF111b, a newly identified anti-angiogenic isoform, in eukaryotic cell linesFariba Dehghanian, Zohreh Hojati
Scientific Reports|August 17, 2021
Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistanceFariba Dehghanian, Shahryar Alavi
Applied Biochemistry and Biotechnology|March 31, 2015
Enhanced expression of bioactive recombinant VEGF-111 with insertion of intronic sequence in mammalian cell linesZohreh Hojati, Fariba Dehghanian
Journal of Molecular Modeling|October 26, 2017
Exploring the crizotinib resistance mechanism of NSCLC with the L1196M mutation using molecular dynamics simulationMaryam Kay, Fariba Dehghanian
Iranian Journal of Neurology|November 20, 2013
The molecular study of IFNβ pleiotropic roles in MS treatmentMaryam Kay, Zohreh Hojati, Fariba Dehghanian
Gene|June 1, 2015
A novel recombinant AzrC protein proposed by molecular docking and in silico analyses to improve azo dye's binding affinityFariba Dehghanian, Maryam Kay, Danial Kahrizi
Journal of Molecular Graphics & Modelling|June 17, 2017
F1174V mutation alters the ALK active conformation in response to Crizotinib in NSCLC: Insight from molecular simulationsFariba Dehghanian, Maryam Kay, Sadeq Vallian
Avicenna Journal of Medical Biotechnology|November 22, 2014
New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological ProcessFariba Dehghanian, Zohreh Hojati, Maryam Kay
Molecular Biology Reports|September 9, 2018
Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetesZahra Azhir, Fariba Dehghanian, Zohreh Hojati
Scientific Reports|May 25, 2026
Integrated transcriptomic network analysis reveals shared immunogenomic regulators between glioma and type 2 diabetes, highlighting VCAN as a prominent markerSara Tavallaei, Fariba Dehghanian, Masih Saboori
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Gene|October 7, 2014
Comparative insight into expression of recombinant human VEGF111b, a newly identified anti-angiogenic isoform, in eukaryotic cell linesFariba Dehghanian, Zohreh Hojati
Scientific Reports|August 17, 2021
Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistanceFariba Dehghanian, Shahryar Alavi
Applied Biochemistry and Biotechnology|March 31, 2015
Enhanced expression of bioactive recombinant VEGF-111 with insertion of intronic sequence in mammalian cell linesZohreh Hojati, Fariba Dehghanian
Journal of Molecular Modeling|October 26, 2017
Exploring the crizotinib resistance mechanism of NSCLC with the L1196M mutation using molecular dynamics simulationMaryam Kay, Fariba Dehghanian
Iranian Journal of Neurology|November 20, 2013
The molecular study of IFNβ pleiotropic roles in MS treatmentMaryam Kay, Zohreh Hojati, Fariba Dehghanian
Gene|June 1, 2015
A novel recombinant AzrC protein proposed by molecular docking and in silico analyses to improve azo dye's binding affinityFariba Dehghanian, Maryam Kay, Danial Kahrizi
Journal of Molecular Graphics & Modelling|June 17, 2017
F1174V mutation alters the ALK active conformation in response to Crizotinib in NSCLC: Insight from molecular simulationsFariba Dehghanian, Maryam Kay, Sadeq Vallian
Avicenna Journal of Medical Biotechnology|November 22, 2014
New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological ProcessFariba Dehghanian, Zohreh Hojati, Maryam Kay
Molecular Biology Reports|September 9, 2018
Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetesZahra Azhir, Fariba Dehghanian, Zohreh Hojati
Scientific Reports|May 25, 2026
Integrated transcriptomic network analysis reveals shared immunogenomic regulators between glioma and type 2 diabetes, highlighting VCAN as a prominent markerSara Tavallaei, Fariba Dehghanian, Masih Saboori
Pageof 4